Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Couzens LK"'
Autor:
Kuck LR; InDevR Inc., 2100 Central Ave., Suite 106, Boulder, CO 80301, United States., Byrne-Nash R; InDevR Inc., 2100 Central Ave., Suite 106, Boulder, CO 80301, United States., Gillis J; InDevR Inc., 2100 Central Ave., Suite 106, Boulder, CO 80301, United States., Bueter K; InDevR Inc., 2100 Central Ave., Suite 106, Boulder, CO 80301, United States., Couzens LK; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States., Eichelberger MC; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States., Rowlen KL; InDevR Inc., 2100 Central Ave., Suite 106, Boulder, CO 80301, United States. Electronic address: rowlen@indevr.com.
Publikováno v:
Vaccine [Vaccine] 2018 May 17; Vol. 36 (21), pp. 2937-2945. Date of Electronic Publication: 2018 Apr 23.
Autor:
Wan H; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Qi L; Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Gao J; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Couzens LK; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Jiang L; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Gao Y; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Sheng ZM; Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Fong S; Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Hahn M; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Khurana S; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Taubenberger JK; Viral Pathogenesis and Evolution Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Eichelberger MC; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA maryna.eichelberger@fda.hhs.gov.
Publikováno v:
Journal of virology [J Virol] 2018 Jan 30; Vol. 92 (4). Date of Electronic Publication: 2018 Jan 30 (Print Publication: 2018).
Autor:
Wan H; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States., Sultana I; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States., Couzens LK; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States., Mindaye S; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States., Eichelberger MC; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, United States. Electronic address: maryna.eichelberger@fda.hhs.gov.
Publikováno v:
Journal of virological methods [J Virol Methods] 2017 Jun; Vol. 244, pp. 23-28. Date of Electronic Publication: 2017 Mar 10.
Autor:
Wang X; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Ilyushina NA; Division of Biotechnology Research and Review II, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Lugovtsev VY; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Bovin NV; Shemyakin Institute of Bioorganic Chemistry, Moscow, Russia., Couzens LK; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Gao J; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Donnelly RP; Division of Biotechnology Research and Review II, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA., Eichelberger MC; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA maryna.eichelberger@fda.hhs.gov hongquan.wan@fda.hhs.gov., Wan H; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA maryna.eichelberger@fda.hhs.gov hongquan.wan@fda.hhs.gov.
Publikováno v:
Journal of virology [J Virol] 2017 Jan 03; Vol. 91 (2). Date of Electronic Publication: 2017 Jan 03 (Print Publication: 2017).
Autor:
Wan H; Division of Viral Products, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, USA., Gao J, Xu K, Chen H, Couzens LK, Rivers KH, Easterbrook JD, Yang K, Zhong L, Rajabi M, Ye J, Sultana I, Wan XF, Liu X, Perez DR, Taubenberger JK, Eichelberger MC
Publikováno v:
Journal of virology [J Virol] 2013 Aug; Vol. 87 (16), pp. 9290-300. Date of Electronic Publication: 2013 Jun 19.